Rocbrutinib
Rocbrutinib is a Bruton's tyrosine kinase inhibitor with antineoplastic effect[1].
Product Specifications
CAS Number
[2485861-07-0]
Product Name Alternative
LP-168
UNSPSC
12352005
Target
EGFR
Type
Reference compound
Related Pathways
JAK/STAT Signaling; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/rocbrutinib.html
Purity
99.76
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
O=C1C2=CC(CC(C)(C3)C)=C3N2CCN1C4=C(C(C(N=C5NC6=CC(NC(C=C)=O)=C(N7[C@H](CN(C8CCOCC8)CC7)C)C=C6)=CN(C)C5=O)=CC=N4)CO
Molecular Formula
C42H51N9O5
Molecular Weight
761.91
References & Citations
[1]Chen Yi, et al. Preparation of pyrrolopyrazines and related heterocycles as inhibitors of BTK and mutants thereof for the treatment of neoplastic, autoimmune and inflammatory disorders. World Intellectual Property Organization, WO2020176403 A1 2020-09-03.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15089968 1 Vial
Lentiviral human RNPEPL1 shRNA (UAS) - Lentiviral human RNPEPL1 shRNA (UAS, iRFP) plasmid
Ask
View Details 
123055 100 µg
Aggrecan (Aggrecan Core Protein, ACAN, Cartilage-specific Proteoglycan Core Protein, CSPCP, Chondroitin Sulfate Proteoglycan Core Protein 1, Chondroitin Sulfate Proteoglycan 1, AGC1, CSPG1, MSK16)
Ask
View Details